CompletedNot Applicable

Effect of PVE on Surgical Outcomes and Long-term Survival in Perihilar Cholangiocarcinoma

South Korea136 participantsStarted 2020-01-30

Plain-language summary

Portal vein embolization is often recommended to reduce the risk of postoperative liver failure and mortality. In this retrospective cohort study, researchers investigated the effect of portal vein embolization in patients with resectable perihilar cholangiocarcinoma bismuth type III and IV.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. patients with Bismuth type III or IV stricture on radiological examination, including computed tomography (CT) or magnetic resonance cholangiography
✓. patients with perihilar cholangiocarcinoma histologically confirmed by surgical resection or forceps biopsy/brush cytology under endoscopic retrograde cholangiopancreatography or through the percutaneous transhepatic biliary drainage tract.

Exclusion criteria

✕. patients with unresectable perihilar cholangiocarcinoma
✕. patients who refused treatment
✕. patients with other concomitant malignancies.

What they're measuring

Overall survival

Timeframe: The time from diagnosis until the date of death or last date of follow-up or end of study up to 24 months

Trial details

NCT IDNCT06222619

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-08-30

View on ClinicalTrials.gov More Biliary Tract Cancer trials